Cargando…

Neo-adjuvant hormone therapy for non-metastatic prostate cancer: a systematic review and meta-analysis of 5,194 patients

BACKGROUND: Neo-adjuvant hormone therapy (NHT) following radical prostatectomy (RP) or radiotherapy has been utilized in the multimodal approach to patients with intermediate- to high-risk prostate cancer (PCa). Herein, we performed a systematic review and meta-analysis of published randomized trial...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Jimeng, Xu, Hua, Zhu, Wenhui, Wu, Fei, Wang, Jianqing, Ding, Qiang, Jiang, Haowen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4344800/ https://www.ncbi.nlm.nih.gov/pubmed/25884478 http://dx.doi.org/10.1186/s12957-015-0503-z

Ejemplares similares

LncRNA DANCR Enhances Angiogenesis to Promote Melanoma Progression Via Sponging miR-5194
por: Jia, Jing, et al.
Publicado: (2023)

Neo–adjuvant hormonal treatment for the undescendent testis – a benefit for the patient?
por: Stein, Raimund
Publicado: (2013)

Changes in Lymphangiogenesis and Vascular Endothelial Growth Factor Expression by Neo‐Adjuvant Hormonal Therapy in Prostate Cancer Patients
por: Asai, Akihiro, et al.
Publicado: (2016)

Nutraceuticals in prostate cancer therapeutic strategies and their neo-adjuvant use in diverse populations
por: Reed, Dominique, et al.
Publicado: (2018)

Role of neo-adjuvant hormonal therapy in the treatment of breast cancer: a review of clinical trials
por: Abrial, Catherine, et al.
Publicado: (2009)

LncRNA DANCR restrained the survival of mycobacterium tuberculosis H37Ra by sponging miR-1301-3p/miR-5194
por: Qu, Yuliang, et al.
Publicado: (2023)

The Efficacy and Safety of (Neo)Adjuvant Therapy for Gastric Cancer: A Network Meta-analysis
por: van den Ende, Tom, et al.
Publicado: (2019)

TRAF2 is a Valuable Prognostic Biomarker in Patients with Prostate Cancer
por: Wei, Bingbing, et al.
Publicado: (2017)

Evaluation of Neo-Adjuvant, Concurrent and Adjuvant Chemotherapy in the Treatment of Head and Neck Squamous Cell Carcinoma: A Meta-Analysis
por: Akhlaghi, Fahimeh, et al.
Publicado: (2014)

CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer
por: Slagter, Astrid E., et al.
Publicado: (2018)

Refined estimates of local recurrence risks by DCIS score adjusting for clinicopathological features: a combined analysis of ECOG-ACRIN E5194 and Ontario DCIS cohort studies
por: Rakovitch, E., et al.
Publicado: (2018)

Anticancer effect of icaritin on prostate cancer via regulating miR‐381‐3p and its target gene UBE2C
por: Hu, Jimeng, et al.
Publicado: (2019)

SAT-194 Correlation of Capillary and Venous Plasma Measurements of Anti-Müllerian Hormone
por: Adams, Hadar, et al.
Publicado: (2019)

Efficacy of Neo-Adjuvant Chemoradiotherapy for Resectable Pancreatic Adenocarcinoma: A PRISMA-Compliant Meta-Analysis and Systematic Review
por: Liu, Wei, et al.
Publicado: (2016)

Lipocalin 2 over-expression facilitates progress of castration-resistant prostate cancer via improving androgen receptor transcriptional activity
por: Ding, Guanxiong, et al.
Publicado: (2016)

Combination of Rapamycin, CI-1040, and 17-AAG Inhibits Metastatic Capacity of Prostate Cancer via Slug Inhibition
por: Ding, Guanxiong, et al.
Publicado: (2013)

Predicting the response of localised oesophageal cancer to neo-adjuvant chemoradiation
por: Gillham, Charles M, et al.
Publicado: (2007)

Colorectal Cancer in the Elderly Patient: The Role of Neo-adjuvant Therapy
por: Dodaro, Concetta Anna, et al.
Publicado: (2019)

The role of neo-adjuvant therapy in cholangiocarcinoma: A systematic review
por: Cremen, Sinead, et al.
Publicado: (2022)

The emerging landscape of neo/adjuvant immunotherapy in renal cell carcinoma
por: Dibajnia, Pooya, et al.
Publicado: (2023)

Effect of adjuvant hormone therapy in patients with prostate cancer: A meta-analysis of randomized controlled trials
por: Liu, Feng, et al.
Publicado: (2018)

Clinical equivalence with G-CSF biosimilars: methodologic approach in a (neo)adjuvant setting in non-metastatic breast cancer
por: Krendyukov, A., et al.
Publicado: (2017)

An Observational Cohort Study on 194 Supraglottic Cancer Patients: Implications for Laser Surgery and Adjuvant Treatment
por: Dyckhoff, Gerhard, et al.
Publicado: (2021)

Successful treatment of gallbladder mixed adenoneuroendocrine carcinoma with neo-adjuvant chemotherapy
por: Song, Wu, et al.
Publicado: (2012)

Differential clonal evolution in oesophageal cancers in response to neo-adjuvant chemotherapy
por: Findlay, John M., et al.
Publicado: (2016)

Neo-adjuvant chemoradiotherapy; an opportunity in sphincter preserving procedure for rectal cancer
por: Mozafar, Mohammad, et al.
Publicado: (2014)

Optimizing (neo)adjuvant treatment of HER2-positive breast cancer
por: Basho, Reva K., et al.
Publicado: (2018)

The Successful Use of Neo Adjuvant Brentuximab Vedotin in the Treatment of BIA-ALCL
por: Allchin, Rebecca L., et al.
Publicado: (2020)

A systematic review of neo-adjuvant radiotherapy in the treatment of breast cancer
por: Ahmed, Muneer, et al.
Publicado: (2021)

Neo-Adjuvant Use of Sorafenib for Hepatocellular Carcinoma Awaiting Liver Transplantation
por: Minoux, Kate, et al.
Publicado: (2022)

Tissue-resident memory T cells in the era of (Neo) adjuvant melanoma management
por: Plunkett, Kai R., et al.
Publicado: (2022)

Future plans of PS 194
por: Knudsen, H, et al.
Publicado: (1995)

Health Tract, No. 194: Memories
Publicado: (1865)

Subject Index to Volume 194
Publicado: (2006)

Systemic therapies for metastatic hormone‐sensitive prostate cancer: network meta‐analysis
por: Mori, Keiichiro, et al.
Publicado: (2021)

Prostate Radiotherapy for Metastatic Hormone-sensitive Prostate Cancer: A STOPCAP Systematic Review and Meta-analysis
por: Burdett, Sarah, et al.
Publicado: (2019)

Phase II study of neo-adjuvant chemotherapy for locally advanced gastric cancer
por: Chang, Alex Yuang-Chi, et al.
Publicado: (2016)

Practical consensus recommendations for neo-adjuvant chemotherapy in triple negative breast cancer
por: Bhattacharyya, G. S., et al.
Publicado: (2018)

Neo-adjuvant chemotherapy in stage IIIC potentially resectable epithelial ovarian cancer
por: Voutsadakis, Ioannis A.
Publicado: (2016)

Evaluation of the use and efficacy of (neo)adjuvant chemotherapy in angiosarcoma: a multicentre study
por: Constantinidou, Anastasia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5rlua2agtd6rut5l46vshtrum4